Coglavax

Clostridium perfringens alfa toxoid, Clostridium perfringens beta toxoid, Clostridium perfringens epsilon toxoid, Toxoid de Clostridium septicum, Toxoid de Clostridium novyi B (oedemantiens), Toxoid de Clostridium tetani, Anacultura de Clostridium chauvoei

Product information

Trade name: Coglavax

Active substance: Clostridium perfringens alfa toxoid, Clostridium perfringens beta toxoid, Clostridium perfringens epsilon toxoid, Toxoid de Clostridium septicum, Toxoid de Clostridium novyi B (oedemantiens), Toxoid de Clostridium tetani, Anacultura de Clostridium chauvoei

Therapeutic group: Organic products

Pharmaceutical form: suspensie injectabilă

Presentation: flacon x 50, 100, 250, 500 ml

Target species: cattle, goats, sheep

Therapeutic action: Bovine, ovine, caprine Imunoprofilaxia enterotoxiemiei provocate de Cl Perfringens tip A, B, C, D si clostridiozelor provocate de Cl Novyi B (oedematiens), Cl. Septicum, Cl. Tetani si Cl. Chauvoei.

Waiting period: 0 zile.

Release mode: Cu prescripţie

Authorization data

Authorization number: 150319

Authorization status: Valida

Date of issue of the authorization: 27-07-2015

Authorization valid until: nelimitata

Manufacturer / Serial Release Company: CEVA PHYLAXIA Veterinary Biologicals Co. Ltd., Ungaria

Licensee: CEVA SANTE ANIMALE ROMANIA, România

Responsible company in Romania: CEVA SANTE ANIMALE ROMANIA